Chemoproteomics-based kinome profiling and target deconvolution of clinical multi-kinase inhibitors in primary chronic lymphocytic leukemia cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Chemoproteomics-based kinome profiling and target deconvolution of clinical multi-kinase inhibitors in primary chronic lymphocytic leukemia cells

Published:2010-10-14 Issue:1 Volume:25 Page:89-100
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Kruse U,Pallasch C P,Bantscheff M,Eberhard D,Frenzel L,Ghidelli S,Maier S K,Werner T,Wendtner C M,Drewes G

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/leu2010233.pdf

Reference50 articles.

1. Druker BJ . Translation of the Philadelphia chromosome into therapy for CML. Blood 2008; 112: 4808–4817.

2. Kumar C, Purandare AV, Lee FY, Lorenzi MV . Kinase drug discovery approaches in chronic myeloproliferative disorders. Oncogene 2009; 28: 2305–2313.

3. Zhang J, Yang PL, Gray NS . Targeting cancer with small molecule kinase inhibitors. Nat Rev Cancer 2009; 9: 28–39.

4. Veldurthy A, Patz M, Hagist S, Pallasch CP, Wendtner CM, Hallek M et al. The kinase inhibitor dasatinib induces apoptosis in chronic lymphocytic leukemia cells in vitro with preference for a subgroup of patients with unmutated IgVH genes. Blood 2008; 112: 1443–1452.

5. Wendtner CM, Eichhorst BF, Hallek MJ . Advances in chemotherapy for chronic lymphocytic leukemia. Semin Hematol 2004; 41: 224–233.

Cited by 70 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Insights into the structural and functional activities of forgotten Kinases: PCTAIREs CDKs;Molecular Cancer;2024-06-29

2. Loss of AR-regulated AFF3 contributes to prostate cancer progression and reduces ferroptosis sensitivity by downregulating ACSL4 based on single-cell sequencing analysis;Apoptosis;2024-03-13

3. An Overview of CDK Enzyme Inhibitors in Cancer Therapy;Current Cancer Drug Targets;2023-09

4. Target proteins profiling of irreversible kinase inhibitor pelitinib and discovery of degradation of PRDX4 by label free chemoproteomics;Journal of Pharmaceutical and Biomedical Analysis;2023-06

5. CDK Dysregulation in Breast Cancer: A Bioinformatics Analysis;Therapeutic potential of Cell Cycle Kinases in Breast Cancer;2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3